Promising disease modifying approach to Duchenne muscular dystrophy with Neu-REFIX® Beta 1,3-1,6 glucan* from Japan; the first such clinical report.
Safety, Fibrosis control and increased muscle strength reported clinically. TOKYO--(BUSINESS WIRE)--#duchenne--Duchenne Muscular Dystrophy (DMD) patients…